Skip to content

Clinical trials

Phase 1 Multiple Sclerosis trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Phase: Phase 1 Country / region: Canada Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20081
20101
20191
20211
20221
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Unknown status2
Active, not recruiting1
Completed1
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
Bayhill Therapeutics1
Courtney Casserly1
Elan Pharmaceuticals1
GAAD Medical Research Institute Inc.1
Hoffmann-La Roche1
Kite, A Gilead Company1
National Cancer Institute (NCI)1
University of Calgary1
Université de Sherbrooke1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis10
Arthritis, Psoriatic1
Arthritis, Rheumatoid1
Autoimmune Diseases1
Colitis, Ulcerative1
Crohn Disease1
Dermatomyositis1
Fatigue1
Hematologic Neoplasms1
Inflammatory Bowel Diseases1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.